SCHEMBL20924765

SCHEMBL20924765

CC(C)CCCCCC(=O)OC(CCCCCC(=O)OC1CCCCC1)CCCCCC(=O)OC1CCCCC1

nearest known ligand 0.58

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ NAAA Q02083 2/20 0.58
▸ SMN1; SMN2 Q16637 1/20 0.45
▸ MAPT P10636 1/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ HTT P42858 1/20 0.38
▸ LMNA P02545 3/20 0.36
▸ CYP2C19 P33261 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ METAP1 P53582 1/20 0.36
▸ EPHX1 P07099 1/20 0.35
▸ HDAC4 P56524 1/20 0.34
▸ HDAC1 Q13547 1/20 0.34
▸ TLR2 O60603 1/20 0.34
▸ PRKCA P17252 1/20 0.34
▸ PRKCE Q02156 1/20 0.34
▸ PRKCQ Q04759 1/20 0.34
▸ PRKCD Q05655 1/20 0.34
▸ EPHX2 P34913 1/20 0.34
▸ CYP19A1 P11511 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20924712 0.99 NAAA (0.57) NAAASMN1; SMN2MAPTMAPK1HTT
SCHEMBL27594966 0.89 NAAA (0.65) NAAASMN1; SMN2HTTCYP2C19ALDH1A1
SCHEMBL16376200 0.86 NAAA (0.55) NAAASMN1; SMN2MAPTMAPK1HTT
SCHEMBL15026848 0.86 NAAA (0.55) NAAASMN1; SMN2MAPTMAPK1HTT
SCHEMBL15009576 0.86 NAAA (0.55) NAAASMN1; SMN2MAPTMAPK1HTT
SCHEMBL15009586 0.84 NAAA (0.54) NAAASMN1; SMN2MAPTMAPK1HTT
SCHEMBL15027493 0.84 NAAA (0.54) NAAASMN1; SMN2MAPTMAPK1HTT
SCHEMBL31323892 0.84 NAAA (0.52) NAAASMN1; SMN2MAPTMAPK1HTT
SCHEMBL16380613 0.83 NAAA (0.69) NAAASMN1; SMN2HTTLMNACYP2C19
SCHEMBL16380552 0.83 NAAA (0.69) NAAASMN1; SMN2HTTLMNACYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2788316-B1 BRANCHED ALKYL AND CYCLOALKYL TERMINATED BIODEGRADABLE LIPIDS FOR THE DELIVERY OF ACTIVE AGENTS ALNYLAM PHARMACEUTICALS INC (US) 2019-04-24 — — EP disclosed
Send feedback